Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Appelbaum

Showing results (101-110 of 258) with videos related to

Pageof 26
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1996
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C Appelbaum
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 3, 1999
Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are highC L Clark, M R Jacobs, P C Appelbaum
Diagnostic Microbiology and Infectious Disease|December 8, 2000
Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazoleK L Credito, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|December 1, 1994
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxoneG A Pankuch, M R Jacobs, P C Appelbaum
Journal of Clinical Microbiology|October 1, 1980
Evaluation of the four-hour Micro-ID technique for direct identification of oxidase-negative, Gram-negative rods from blood culturesP C Appelbaum, S F Schick, J A Kellogg
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C Appelbaum
Pageof 26

Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Antimicrobial Agents and Chemotherapy|February 1, 1996
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C Appelbaum
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 3, 1999
Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are highC L Clark, M R Jacobs, P C Appelbaum
Diagnostic Microbiology and Infectious Disease|December 8, 2000
Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazoleK L Credito, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|December 1, 1994
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxoneG A Pankuch, M R Jacobs, P C Appelbaum
Journal of Clinical Microbiology|October 1, 1980
Evaluation of the four-hour Micro-ID technique for direct identification of oxidase-negative, Gram-negative rods from blood culturesP C Appelbaum, S F Schick, J A Kellogg
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C Appelbaum
Pageof 26